Supernus Pharmaceuticals, Inc. (SUPN) News
Latest headlines that mention SUPN, newest first · each headline opens the original publisher
- Last price
- $41.00
- Day change
- -0.51%
- Next earnings
- 2026-10-29 AMC
SUPN headlines
latest coverageIt's effecting a "merger of equals" with a peer.
Supernus Pharmaceuticals delivers specialty therapies for CNS disorders, targeting healthcare providers and specialty pharmacies nationwide.
SUPN news alerts
Get an alert by email or push when a new headline mentions SUPN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.